Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sujit Kumar Debnath, Rohit Srivastava, Monalisha Debnath & Abdelwahab Omri. (2021) Status of inhalable antimicrobial agents for lung infection: progress and prospects. Expert Review of Respiratory Medicine 15:10, pages 1251-1270.
Read now
Read now
Mohammed M Mehanna, Salma M Mohyeldin & Nazik A Elgindy. (2019) Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery. International Journal of Nanomedicine 14, pages 9089-9112.
Read now
Read now
Nguyen Hoai An Le, Hoang Van Phan, Jiaqi Yu, Hak-Kim Chan, Adrian Neild & Tuncay Alan. (2018) Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers. International Journal of Nanomedicine 13, pages 1353-1359.
Read now
Read now
Heba F. Salem, Rasha M. Kharshoum, Lekaa F. Abdel Hakim & Mohamed E. Abdelrahim. (2016) Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler. Journal of Liposome Research 26:4, pages 324-335.
Read now
Read now
Aly A Abdelbary, Abdulaziz M Al-mahallawi, Mohamed E Abdelrahim & Ahmed MA Ali. (2015) Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. International Journal of Nanomedicine 10, pages 6339-6353.
Read now
Read now
Federica Leone & Roberta Cavalli. (2015) Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations. Expert Opinion on Drug Delivery 12:10, pages 1607-1625.
Read now
Read now
Wei Meng Lim, Paruvathanahalli Siddalingam Rajinikanth, Chitneni Mallikarjun & Yew Beng Kang. (2014) Formulation and delivery of itraconazole to the brain using a nanolipid carrier system. International Journal of Nanomedicine 9, pages 2117-2126.
Read now
Read now
Articles from other publishers (36)
Petra Party, Márk László Klement, Piroska Szabó-Révész & Rita Ambrus. (2023) Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15:2, pages 545.
Crossref
Crossref
Manisha Patel, Rupa Mazumder, Rakhi Mishra & Kamal Kant Kaushik. (2022) Potential of Nanotechnology-based Formulations in Combating Pulmonary
Infectious Diseases: A Current Scenario. Current Pharmaceutical Design 28:42, pages 3413-3427.
Crossref
Crossref
Popat Kumbhar, Arehalli Manjappa, Rohit Shah, Niraj Kumar Jha, Sachin Kumar Singh, Kamal Dua, John Disouza & Vandana Patravale. (2022) Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. Journal of Controlled Release 341, pages 1-15.
Crossref
Crossref
Anand Maurya, Anurag Kumar Singh, Bhuwanendra Singh, Nidhi Singh, Sachin Kumar Agrahari, Arati Rai & Gopal Kumar Rai. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
107
124
.
Zachary Warnken, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2022. Formulating Poorly Water Soluble Drugs. Formulating Poorly Water Soluble Drugs
1
31
.
Heejun Park, Eun-Sol Ha & Min-Soo Kim. (2021) Surface modification strategies for high-dose dry powder inhalers. Journal of Pharmaceutical Investigation 51:6, pages 635-668.
Crossref
Crossref
Bader M. Jarai, Zachary Stillman, Kartik Bomb, April M. Kloxin & Catherine A. Fromen. (2020) Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19. ACS Biomaterials Science & Engineering 7:5, pages 1742-1764.
Crossref
Crossref
Qiuying Liao & Jenny K.W. Lam. (2021) Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses. Current Pharmaceutical Design 27:12, pages 1453-1468.
Crossref
Crossref
Ameeduzzafar, Mohd Qumber, Nabil K Alruwaili, Syed Nasir Abbas Bukhari, Khalid Saad Alharbi, Syed Sarim Imam, Muhammad Afzal, Bader Alsuwayt, Ali Mujtaba & Asgar Ali. (2020) BBD-Based Development of Itraconazole Loaded Nanostructured Lipid Carrier for Topical Delivery: In Vitro Evaluation and Antimicrobial Assessment. Journal of Pharmaceutical Innovation 16:1, pages 85-98.
Crossref
Crossref
Elisa Lewington-Gower, Ley Chan & Anand Shah. (2021) Review of current and future therapeutics in ABPA. Therapeutic Advances in Chronic Disease 12, pages 204062232110470.
Crossref
Crossref
Birendra Chaurasiya & You-Yang Zhao. (2020) Dry Powder for Pulmonary Delivery: A Comprehensive Review. Pharmaceutics 13:1, pages 31.
Crossref
Crossref
Maria Malamatari, Anastasia Charisi, Stavros Malamataris, Kyriakos Kachrimanis & Ioannis Nikolakakis. (2020) Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation. Processes 8:7, pages 788.
Crossref
Crossref
Gabriella Costabile, Romina Provenzano, Alberto Azzalin, Viola Camilla Scoffone, Laurent R. Chiarelli, Valeria Rondelli, Isabelle Grillo, Thomas Zinn, Alexander Lepioshkin, Svetlana Savina, Agnese Miro, Fabiana Quaglia, Vadim Makarov, Tom Coenye, Paola Brocca, Giovanna Riccardi, Silvia Buroni & Francesca Ungaro. (2020) PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection. Nanomedicine: Nanotechnology, Biology and Medicine 23, pages 102113.
Crossref
Crossref
Rayehe Teymouri Rad, Simin Dadashzadeh, Alireza Vatanara, Sonia Alavi, Elham Ghasemian & Seyed Alireza Mortazavi. (2019) Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment. European Journal of Pharmaceutical Sciences 133, pages 275-286.
Crossref
Crossref
Rémi Rosière, Karim Amighi & Nathalie Wauthoz. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
249
268
.
Zhengwei Huang, Ling Lin, Cushla McGoverin, Hu Liu, Lili Wang, Qi (Tony) Zhou, Ming Lu & Chuanbin Wu. (2018) Dry powder inhaler formulations of poorly water-soluble itraconazole: A balance between in-vitro dissolution and in-vivo distribution is necessary. International Journal of Pharmaceutics 551:1-2, pages 103-110.
Crossref
Crossref
Stephen P. Newman. (2018) Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases. Advanced Drug Delivery Reviews 133, pages 5-18.
Crossref
Crossref
Kaidi Li, Naixin Liang, Huaxia Yang, Hongsheng Liu & Shanqing Li. (2017)
Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both
in vitro
and
in vivo
. Oncotarget 8:67, pages 111318-111332.
Crossref
Crossref
Zimeng Wang & Samantha A. Meenach. (2017) Optimization of Acetalated Dextran–Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying. Journal of Pharmaceutical Sciences 106:12, pages 3539-3547.
Crossref
Crossref
Stephen P Newman. (2017) Drug delivery to the lungs: challenges and opportunities. Therapeutic Delivery 8:8, pages 647-661.
Crossref
Crossref
Maria Malamatari, Satyanarayana Somavarapu, Kyriakos Kachrimanis, Graham Buckton & Kevin M.G. Taylor. (2017) Preparation of respirable nanoparticle agglomerates of the low melting and ductile drug ibuprofen: Impact of formulation parameters. Powder Technology 308, pages 123-134.
Crossref
Crossref
Biswajit Mukherjee, Paramita Paul, Lopamudra Dutta, Samrat Chakraborty, Moumita Dhara, Laboni Mondal & Soma Sengupta. 2017. Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics. Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics
261
280
.
Maria Malamatari, Satyanarayana Somavarapu, Kyriakos Kachrimanis, Mark Bloxham, Kevin M.G. Taylor & Graham Buckton. (2016) Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: The influence of mannitol as a co-milling agent. International Journal of Pharmaceutics 514:1, pages 200-211.
Crossref
Crossref
Zachary Warnken, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2016. Formulating Poorly Water Soluble Drugs. Formulating Poorly Water Soluble Drugs
1
39
.
Maria Malamatari, Satyanarayana Somavarapu, Mark Bloxham & Graham Buckton. (2015) Nanoparticle agglomerates of indomethacin: The role of poloxamers and matrix former on their dissolution and aerosolisation efficiency. International Journal of Pharmaceutics 495:1, pages 516-526.
Crossref
Crossref
RÉMI ROSIÈRE, MICHEL GELBCKE, VÉRONIQUE MATHIEU, PIERRE VAN ANTWERPEN, KARIM AMIGHI & NATHALIE WAUTHOZ. (2015) New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy. International Journal of Oncology 47:3, pages 1131-1142.
Crossref
Crossref
Yahya Rahimpour, Hamed Hamishehkar & Ali Nokhodchi. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery
123
142
.
Nathalie Wauthoz & Karim Amighi. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery
87
122
.
Priya Muralidharan, Monica Malapit, Evan Mallory, Don HayesJr.Jr. & Heidi M. Mansour. (2015) Inhalable nanoparticulate powders for respiratory delivery. Nanomedicine: Nanotechnology, Biology and Medicine 11:5, pages 1189-1199.
Crossref
Crossref
Zhi Hui Loh, Asim Kumar Samanta & Paul Wan Sia Heng. (2015) Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences 10:4, pages 255-274.
Crossref
Crossref
Qi (Tony) Zhou, Sharon Shui Yee Leung, Patricia Tang, Thaigarajan Parumasivam, Zhi Hui Loh & Hak-Kim Chan. (2015) Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Advanced Drug Delivery Reviews 85, pages 83-99.
Crossref
Crossref
Romain Merlos, Karim Amighi & Nathalie Wauthoz. (2014) Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis. Current Fungal Infection Reports 8:4, pages 331-342.
Crossref
Crossref
Tetsuya Ozeki & Tatsuaki Tagami. (2014) Drug/polymer nanoparticles prepared using unique spray nozzles and recent progress of inhaled formulation. Asian Journal of Pharmaceutical Sciences 9:5, pages 236-243.
Crossref
Crossref
John Gar Yan Chan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung & Hak-Kim Chan. (2014) Advances in Device and Formulation Technologies for Pulmonary Drug Delivery. AAPS PharmSciTech 15:4, pages 882-897.
Crossref
Crossref
Mukta Paranjpe & Christel Müller-Goymann. (2014) Nanoparticle-Mediated Pulmonary Drug Delivery: A Review. International Journal of Molecular Sciences 15:4, pages 5852-5873.
Crossref
Crossref
Christophe Duret, Romain Merlos, Nathalie Wauthoz, Thami Sebti, Francis Vanderbist & Karim Amighi. (2014) Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 46-54.
Crossref
Crossref